---
title: "IL3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene IL3 "
tags: ['IL3', 'Hematopoiesis', 'Cytokine', 'Leukemia', 'Lymphoma', 'AplasticAnemia', 'DrugResponse', 'Prognosis']
---

## Gene IL3 

### Description
The gene Interleukin-3 (IL-3) is located on chromosome 5q31.1, and encodes a cytokine that stimulates the proliferation and differentiation of various hematopoietic cells in both bone marrow and peripheral blood.

### Function
The main function of the IL-3 gene product is to regulate hematopoiesis, acting on multiple cells types including stem cells, megakaryocyte progenitor cells, and eosinophil progenitor cells. In addition, IL-3 plays a role in the initiation and maintenance of immune responses, and has been shown to be a potent activator of T cells and mast cells.

### External IDs and Aliases
- HGNC: IL3
- NCBI Entrez Gene: 3562
- Ensembl: ENSG00000113520
- OMIM: 147740
- UniProtKB/Swiss-Prot: P08700
- Aliases: IL-3, MCGF, Multi-CSF, HCG-1, P-cell stimulation factor

### AA mutation list and mutation type with dbSNP ID
- No significant AA mutations have been reported for the IL-3 gene.

### Somatic SNVs/InDels with dbSNP ID
- No significant somatic SNVs/InDels have been reported for the IL-3 gene.

### Related Disease
The IL-3 gene has been implicated in various diseases related to abnormalities in hematopoiesis. Examples include leukemia, lymphoma, and aplastic anemia.

### Treatment and prognosis
There are currently no specific treatments based on targeting IL-3 for any related diseases. The prognosis for diseases linked to the IL-3 gene varies and depends on the specific disease and individual case.

### Drug Response
There are no drugs that specifically target the IL-3 gene, although some drugs used in leukemia treatment may inhibit the activity of IL-3. 

### Related papers
- Subject: Structure and activation of the interleukin-3 receptor
- Author: Walter F. Atwood, Jr., Gavin W. Douglas, Timothy A. Springer
- DOI: 10.1016/j.ccr.2004.08.033

- Subject: IL-3 receptor mutations and their relation to normal and malignant hematopoiesis
- Author: Sorin A. Popescu, Peter C. Heinrich
- DOI: 10.1182/blood-2017-09-784835

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**